Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features
Reshma Jagsi(Emory University), Mahmoud El‐Tamer(Memorial Sloan Kettering Cancer Center), Jean L. Wright(University of North Carolina at Chapel Hill), Abram Recht(Beth Israel Deaconess Medical Center), Jon Sharp(University of Michigan), Kent A. Griffith(University of Michigan), Mahvish Muzaffar(East Carolina University), L. Lee(Northwell Health), Meena S. Moran(Cleveland Clinic), Anne F. Schott(University of Michigan), Simon N. Powell(Memorial Sloan Kettering Cancer Center), Bruce G. Haffty(Rutgers, The State University of New Jersey), Alphonse G. Taghian(Massachusetts General Hospital), Eleanor Harris(St. Luke's University Health Network), Michael S. Sabel(Michigan Cancer Research Consortium), K.C. Horst(Stanford Cancer Institute), Candice Johnstone(Medical College of Wisconsin), Asal Rahimi(Jackson Memorial Hospital), T.O. Thomas(Loyola University Chicago), Gary M. Freedman(Fox Chase Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 1, 2019
Cited by 6
Related Papers
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k